Aspen opens anaesthetic building as part of €100M investment in France

Aspen Pharmacare has expanded its sterile production site at Notre Dame de Bondeville in France with a new anaesthetic facility and high-speed filling lines for thrombosis products, part of a €100 million investment. The expansion will add capacity for 80 million blow-fill-seal anaesthetic units and 180 million pre-filled syringes annually, with commercial production expected in 2020.

“The new state-of-the-art facility for anaesthetics, together with the new high-speed pre-filled syringe filling and automatic visual inspection lines for thrombosis products, comprise a substantial part of the €100 million investment.”aspenpharma.com

• 1 source
• aspenpharma.comAspen opens anaesthetic building as part of €100 million investment at its French-based site | Aspen PharmacarebpcJun 18, 2019

Summarized from public sources; check the original articles before acting on it.